Your browser is no longer supported. Please, upgrade your browser.
Settings
BDSI BioDelivery Sciences International, Inc. daily Stock Chart
BDSI [NASD]
BioDelivery Sciences International, Inc.
Index- P/E- EPS (ttm)-0.74 Insider Own4.80% Shs Outstand73.60M Perf Week2.61%
Market Cap376.10M Forward P/E39.92 EPS next Y0.13 Insider Trans-5.15% Shs Float65.56M Perf Month8.03%
Income-46.40M PEG- EPS next Q-0.08 Inst Own58.10% Short Float5.23% Perf Quarter57.23%
Sales55.60M P/S6.76 EPS this Y-883.40% Inst Trans7.61% Short Ratio4.02 Perf Half Y89.26%
Book/sh0.42 P/B12.17 EPS next Y94.40% ROA-44.30% Target Price7.25 Perf Year143.33%
Cash/sh0.60 P/C8.59 EPS next 5Y25.00% ROE-172.70% 52W Range1.70 - 5.36 Perf YTD38.11%
Dividend- P/FCF- EPS past 5Y13.50% ROI-29.10% 52W High-4.66% Beta0.48
Dividend %- Quick Ratio2.80 Sales past 5Y37.40% Gross Margin71.60% 52W Low200.59% ATR0.27
Employees164 Current Ratio3.10 Sales Q/Q44.00% Oper. Margin-42.40% RSI (14)59.51 Volatility5.00% 5.97%
OptionableYes Debt/Eq1.74 EPS Q/Q65.90% Profit Margin-83.30% Rel Volume0.99 Prev Close5.30
ShortableYes LT Debt/Eq1.74 EarningsMar 14 AMC Payout- Avg Volume851.49K Price5.11
Recom- SMA204.71% SMA5011.73% SMA20045.79% Volume841,041 Change-3.58%
Mar-20-19Initiated SunTrust Buy $7
Jan-31-19Resumed Janney Buy $5
Jan-26-18Initiated Seaport Global Securities Buy $5
Aug-14-17Resumed Cantor Fitzgerald Overweight $4.50
Aug-10-17Reiterated H.C. Wainwright Buy $4 → $5
May-26-17Initiated H.C. Wainwright Buy $4
May-17-17Upgrade Cantor Fitzgerald Neutral → Overweight
May-12-16Reiterated Piper Jaffray Overweight $6 → $4
May-11-16Downgrade Cantor Fitzgerald Buy → Hold
May-04-16Reiterated FBR Capital Outperform $12 → $9
Mar-14-16Reiterated Laidlaw Buy $17 → $11
Mar-11-16Reiterated FBR Capital Outperform $13 → $12
Feb-08-16Initiated Piper Jaffray Overweight
Nov-10-15Reiterated FBR Capital Mkt Perform $17 → $14
Nov-04-15Initiated Cantor Fitzgerald Buy
May-12-15Reiterated Cantor Fitzgerald Buy $17 → $12
May-11-15Reiterated ROTH Capital Buy $16 → $14
Apr-22-15Resumed Piper Jaffray Overweight
Apr-02-15Initiated FBR Capital Outperform $19
Mar-31-15Reiterated ROTH Capital Buy $18 → $16
Mar-22-19 06:24PM  Lifshitz & Miller LLP Announces Investigation of Alta Mesa Resources, Inc., American Renal Associates LLC, Belden, Inc., BioDelivery Sciences, Inc., Blue Valley Bank Corp., Bridgepoint Education, Inc., and Care.com, Inc. PR Newswire
08:25AM  Edited Transcript of BDSI earnings conference call or presentation 14-Mar-19 8:30pm GMT Thomson Reuters StreetEvents
Mar-21-19 05:45PM  BioDelivery Sciences International (BDSI) Gains But Lags Market: What You Should Know Zacks
Mar-19-19 02:26PM  Catalyst (CPRX) Reports Wider Q4 Loss, Focuses on Firdapse Zacks
Mar-18-19 06:44PM  Bristol-Myers & Pfizer Release Phase IV Data on Eliquis Zacks
Mar-15-19 10:23AM  BioDelivery (BDSI) Q4 Earnings In Line, Sales Beat, Stock Up Zacks +7.79%
Mar-14-19 08:20PM  Biodelivery Sciences International Inc (BDSI) Q4 2018 Earnings Conference Call Transcript Motley Fool
07:45PM  BioDelivery: 4Q Earnings Snapshot Associated Press
04:05PM  BioDelivery Sciences Reports Strong 2018 Results and 2019 Expectations ACCESSWIRE
02:30PM  BioDelivery Sciences International, Inc. to Host Earnings Call ACCESSWIRE
Mar-13-19 12:50PM  Aerie (AERI) Receives FDA Nod for Rocklatan to Treat Glaucoma Zacks
Mar-12-19 10:58AM  BioDelivery Sciences Investigated by Block & Leviton LLP For Violations of Federal Securities Laws GlobeNewswire -6.03%
09:59AM  Alnylam Files Application for Hypertension Candidate in UK Zacks
Mar-11-19 02:38PM  What Kind Of Shareholder Appears On The BioDelivery Sciences International, Inc.s (NASDAQ:BDSI) Shareholder Register? Simply Wall St.
10:35AM  AMAG's Stock Down as Pregnancy Drug Fails in PROLONG Study Zacks
10:00AM  What Makes BioDelivery Sciences International (BDSI) a Strong Momentum Stock: Buy Now? Zacks
09:56AM  Will the Decade-Old Bull Market Momentum Last? 5 Picks Zacks
Mar-05-19 04:36PM  What's in Store for BioSpecifics (BSTC) This Earnings Season? Zacks
04:06PM  What's in the Cards for Corbus (CRBP) This Earnings Season? Zacks
08:44AM  REGENXBIO (RGNX) in Focus: Stock Moves 5.1% Higher Zacks
Mar-04-19 11:40PM  Champions Oncology (CSBR) Q3 Earnings: What's in Store? Zacks
11:34PM  What's in the Cards for Novavax (NVAX) This Earnings Season? Zacks
08:58AM  What's in the Cards for Aeterna (AEZS) This Earnings Season? Zacks
Mar-01-19 02:20PM  Endo (ENDP) Q4 Earnings & Revenues Beat Estimates, Shares Up Zacks
11:59AM  Amicus (FOLD) Reports Wider-than-Expected-Loss for 2018 Zacks
10:27AM  The Meet Group (MEET) to Report Q4 Earnings: What's in Store? Zacks
Feb-28-19 11:12AM  Horizon Pharma's (HZNP) Stock Up on Q4 Earnings & Sales Beat Zacks
08:52AM  Zacks.com featured expert Kevin Matras highlights: First, Clearfield, BioDelivery Sciences International, MGIC Investment and Kratos Defense & Security Solutions Zacks
Feb-27-19 07:19AM  Editas (EDIT) to Report Q4 Earnings: What's in the Cards? Zacks
07:13AM  Jazz Pharma (JAZZ) Q4 Earnings & Sales Beat, Stock Up 8% Zacks
06:24AM  5 Affordable Breakout Stocks for Superlative Returns Zacks
Feb-25-19 07:57AM  What's in the Cards for Nektar (NKTR) This Earnings Season? Zacks
Feb-22-19 04:53PM  Amgen Starts Phase III Enrollment for Heart Failure Drug Zacks +5.71%
04:43PM  What's in Store for Vericel (VCEL) This Earnings Season? Zacks
04:36PM  What's in Store for Teladoc's (TDOC) Q4 Earnings? Zacks
02:46PM  bluebird (BLUE) Q4 Earnings Beat Estimates, Revenues Up Y/Y Zacks
09:23AM  BioMarin (BMRN) Q4 Earnings & Sales Miss, Shares Decline Zacks
Feb-21-19 05:45PM  BioDelivery Sciences International (BDSI) Dips More Than Broader Markets: What You Should Know Zacks
09:34AM  Agios' Tibsovo Gets FDA Priority Review in First-Line Cancer Zacks
07:45AM  BioDelivery Sciences to Report Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Feb-20-19 09:45AM  Key Factors to Know Ahead of TransEnterix (TRXC) Q4 Earnings Zacks
09:12AM  3 Small Biotechs to Watch as Earnings Season Winds Down TheStreet.com
07:41AM  Ultragenyx (RARE) Posts Narrower-Than-Expected Loss in Q4 Zacks
Feb-19-19 10:07AM  What's in Store for Sangamo (SGMO) This Earnings Season? Zacks
07:20AM  Factors of Influence in 2019, Key Indicators and Opportunity within Procter & Gamble, Hertz Global, NN, Omnicell, BioDelivery Sciences International, and Movado Group New Research Emphasizes Economic Growth GlobeNewswire
Feb-18-19 08:16AM  What's in the Cards for Amarin (AMRN) This Earnings Season? Zacks
Feb-15-19 02:25PM  Agios (AGIO) Q4 Earnings Beat, Tibsovo Sales Push Up Stock Zacks
10:29AM  Acorda (ACOR) Q4 Earnings and Revenues Surpass Estimates Zacks
08:54AM  Key Factors Likely to Shape CVS Health's (CVS) Q4 Earnings Zacks
Feb-14-19 10:45AM  The Zacks Analyst Blog Highlights: BioDelivery, Cytokinetics, Celldex, Aduro and Aeterna Zacks
Feb-13-19 08:36AM  5 Tiny Biotech Stocks With Superb Growth Potential Zacks
Feb-11-19 09:19AM  Can M&A Activity Drive Quest Diagnostics (DGX) Q4 Earnings? Zacks
Feb-05-19 05:22PM  Penny Stocks to Watch for February 2019 Investopedia
Feb-04-19 09:09AM  What's in the Cards for Glaxo (GSK) This Earnings Season? Zacks
08:03AM  BioDelivery Announces Expanded Preferred Insurance Coverage For BELBUCA® GlobeNewswire
Jan-29-19 10:11AM  Vertex's Kalydeco Wins Health Canada Nod to Treat CF in Kids Zacks
Jan-23-19 10:00AM  BioDelivery Sciences International (BDSI) is a Great Momentum Stock: Should You Buy? Zacks
Jan-15-19 09:04AM  Zacks.com featured highlights include: Rent-A-Center, BioDelivery , Seabridge, Marchex and DSP Zacks
07:30AM  BioDelivery Sciences Appoints Terry Coelho as Chief Financial Officer GlobeNewswire
Jan-14-19 08:35AM  5 Breakout Stocks Offering Impressive Returns Zacks
Jan-03-19 02:48PM  From Iqvia to Red Hat: These execs raked in millions from stock sales in 2018 American City Business Journals
Dec-27-18 09:23AM  Stocks down in December for pharma firms in the Triangle American City Business Journals
Dec-26-18 10:15AM  Should You Be Worried About Insider Transactions At BioDelivery Sciences International, Inc. (NASDAQ:BDSI)? Simply Wall St.
Dec-20-18 05:41AM  BioDelivery Sciences International, Inc. (BDSI): Are Hedge Funds Right About This Stock? Insider Monkey -5.85%
Dec-13-18 07:00AM  Antares Pharma Announces the Appointment of Peter S. Greenleaf to Companys Board of Directors GlobeNewswire
Dec-11-18 08:30AM  Avadel Pharmaceuticals Appoints Kevin Kotler to the Companys Board of Directors GlobeNewswire
Dec-08-18 09:30AM  BioDelivery (BDSI) Down 1.6% Since Last Earnings Report: Can It Rebound? Zacks
Nov-20-18 09:52PM  Edited Transcript of BDSI earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Nov-12-18 09:25AM  BioDelivery (BDSI) Q3 Earnings Beat, Sales In Line, Stock Up Zacks
09:00AM  Consolidated Research: 2018 Summary Expectations for Murphy Oil, REGENXBIO, CRA International,Inc, Carriage Services, CONMED, and BioDelivery Sciences International Fundamental Analysis, Key Performance Indications GlobeNewswire
Nov-08-18 07:55PM  BioDelivery Sciences International (BDSI) Reports Q3 Loss, Misses Revenue Estimates Zacks
06:50PM  BioDelivery: 3Q Earnings Snapshot Associated Press
04:05PM  BioDelivery Sciences Reports Strong Third Quarter 2018 Financial Results GlobeNewswire
Nov-05-18 02:29PM  The most valuable public companies in the Triangle (Slideshow) American City Business Journals
07:55AM  5 Drug/Biotech Stocks Set to Trump Estimates in Q3 Earnings Zacks
Nov-01-18 04:10PM  BioDelivery Sciences Announces Further Significant Expanded Preferred Coverage For BELBUCA® GlobeNewswire
11:28AM  BioDelivery Sciences International (BDSI) Expected to Beat Earnings Estimates: Should You Buy? Zacks
08:30AM  Penny Stocks to Buy Using Technical Analysis for November 2018 Investopedia
Oct-29-18 08:30AM  BioDelivery Sciences Announces Changes to its Executive Leadership Team GlobeNewswire
Oct-23-18 08:00AM  BioDelivery Sciences to Report Third Quarter 2018 Financial Results on November 8, 2018 GlobeNewswire
Oct-17-18 08:55AM  New Research: Key Drivers of Growth for IDT, Live Nation Entertainment, BioDelivery Sciences International, Spero Therapeutics, Aimmune Therapeutics, and Cars Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Oct-12-18 09:50AM  Can The Uptrend Continue for BioDelivery Sciences International (BDSI)? Zacks
Oct-05-18 12:31PM  From Iqvia's Bousbib to Red Hat's Whitehurst: Who made the most from inside stock sales in 3Q2018 American City Business Journals
Oct-01-18 08:23AM  Who Are The Major Shareholders Of BioDelivery Sciences International Inc (NASDAQ:BDSI)? Simply Wall St.
Sep-25-18 08:00AM  BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2018 Healthcare Conference GlobeNewswire
Sep-17-18 12:49PM  BDSI files suit against generic drugmaker American City Business Journals
Sep-13-18 07:30AM  BioDelivery Sciences to Host Institutional Investor and Analyst Day on Friday, October 5, 2018 GlobeNewswire
Sep-10-18 08:00AM  BioDelivery Sciences to Present at the 2018 Janney Montgomery Scott Healthcare Conference GlobeNewswire
Sep-04-18 02:38PM  Inside The List: Highest-Paid Public Company CEOs American City Business Journals
Aug-26-18 11:55PM  Edited Transcript of BDSI earnings conference call or presentation 9-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-23-18 08:10AM  Factors of Influence in 2018, Key Indicators and Opportunity within Aurora Cannabis, Canopy Growth, MobileIron, Sangamo Therapeutics, BioDelivery Sciences International, and First Solar New Research Emphasizes Economic Growth GlobeNewswire
Aug-21-18 08:00AM  BioDelivery Sciences to Present at the Rodman & Renshaw 20th Annual Global Investment Conference GlobeNewswire
Aug-15-18 09:26AM  BioDelivery Sciences Secures Significant Expanded Preferred Coverage for BELBUCA® GlobeNewswire
Aug-10-18 05:25PM  Some highs, lows as RTP biotech companies report earnings American City Business Journals
09:18AM  BioDelivery (BDSI) Q2 Loss Narrows, Sales Miss, Shares Down Zacks
Aug-09-18 05:50PM  BioDelivery Sciences International (BDSI) Reports Q2 Loss, Misses Revenue Estimates Zacks
04:44PM  BioDelivery: 2Q Earnings Snapshot Associated Press
04:05PM  BioDelivery Sciences Reports Strong Second Quarter 2018 Financial Results GlobeNewswire
02:30PM  BioDelivery Sciences International, Inc. to Host Earnings Call ACCESSWIRE
Aug-08-18 09:18AM  Drug/Biotech Stock Q2 Earnings on Aug 9: PRGO, BDSI & More Zacks
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products principally in the areas of pain management and addiction. The company provides its products based on its patented BioErodible MucoAdhesive drug delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film for the treatment of opioid dependence; and ONSOLIS, a fentanyl buccal soluble film to treat breakthrough pain in opioid patients with cancer. The company also develops buprenorphine extended release injection, an injectable microparticle formulation of buprenorphine for the treatment of opioid dependence and chronic pain. BioDelivery Sciences International, Inc. has a licensing and development agreement with Evonik Corporation and Meda AB. The company was founded in 1997 and is headquartered in Raleigh, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sirgo Mark ADirectorMar 21Sale5.209,05047,0602,499,955Mar 22 06:00 PM
ODONNELL FRANCIS E JRDirectorMar 21Sale5.2171,690373,505614,254Mar 22 06:01 PM
ODONNELL FRANCIS E JRDirectorMar 20Option Exercise0.0077,5000661,187Mar 22 06:01 PM
Plesha Scott M.See RemarksMar 20Option Exercise0.0029,1660261,503Mar 22 06:02 PM
ODONNELL FRANCIS E JRDirectorMar 01Option Exercise0.0046,0000544,187Mar 01 06:43 PM
Plesha Scott M.See RemarksMar 01Option Exercise0.0011,6660224,004Mar 01 06:46 PM
ODONNELL FRANCIS E JRDirectorMar 01Sale5.0723,000116,610521,187Mar 01 06:43 PM
Sirgo Mark ADirectorJan 02Option Exercise3.059,17527,9842,498,717Jan 04 06:02 PM
ODONNELL FRANCIS E JRDirectorJan 02Sale3.648,00029,120506,187Jan 04 06:01 PM
Sirgo Mark ADirectorJan 02Sale3.579,17532,7552,489,542Jan 04 06:02 PM
Sirgo Mark ADirectorDec 27Sale2.9110,00029,1002,489,542Dec 28 06:07 PM
De Paolantonio Ernest RobertCFO, Secretary and TreasurerDec 04Sale3.7916,16161,250140,548Dec 06 06:01 PM
ODONNELL FRANCIS E JRDirectorDec 03Sale3.728,00029,760514,187Dec 04 06:00 PM
ODONNELL FRANCIS E JRDirectorNov 01Sale3.848,00030,720522,187Nov 02 06:00 PM
ODONNELL FRANCIS E JRDirectorOct 01Sale2.758,00022,000530,187Oct 03 06:00 PM
ODONNELL FRANCIS E JRDirectorSep 13Option Exercise0.00108,5000569,121Sep 14 06:00 PM
ODONNELL FRANCIS E JRDirectorSep 13Sale2.8484,372239,616538,187Sep 14 06:00 PM
ODONNELL FRANCIS E JRDirectorSep 12Option Exercise0.00133,3330520,482Sep 14 06:00 PM
ODONNELL FRANCIS E JRDirectorSep 12Sale2.8366,667188,668453,815Sep 14 06:00 PM
ODONNELL FRANCIS E JRDirectorAug 17Sale2.798,00022,320387,149Aug 21 05:30 PM
KOTLER KEVINDirectorAug 14Option Exercise0.003,12403,124Aug 16 05:01 PM
Greenleaf PeterDirectorAug 14Option Exercise0.003,64403,644Aug 16 05:01 PM
Davis Todd CDirectorAug 14Option Exercise0.003,12403,124Aug 16 05:00 PM
Watson W. MarkDirectorAug 14Option Exercise0.009,740011,240Aug 16 05:00 PM
Plesha Scott M.PresidentAug 10Option Exercise0.0036,4320193,588Aug 14 05:03 PM
ODONNELL FRANCIS E JRDirectorJun 25Option Exercise2.0137,50075,375422,674Jun 27 07:32 PM
Sirgo Mark ADirectorApr 10Sale2.06100,000206,0002,499,542Apr 13 07:02 PM
De Paolantonio Ernest RobertCFO, Secretary and TreasurerApr 06Sale2.0633,25568,505156,709Apr 06 06:01 PM
De Paolantonio Ernest RobertCFO, Secretary and TreasurerApr 05Sale2.1230,90065,508189,864Apr 06 06:01 PM
De Paolantonio Ernest RobertCFO, Secretary and TreasurerApr 03Option Exercise0.00123,1330220,864Apr 06 06:01 PM